Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Genetics of synchronous uterine and ovarian endometrioid carcinoma: combined analyses of loss of heterozygosity, PTEN mutation, and microsatellite instability.

Fujii H, Matsumoto T, Yoshida M, Furugen Y, Takagaki T, Iwabuchi K, Nakata Y, Takagi Y, Moriya T, Ohtsuji N, Ohtsuji M, Hirose S, Shirai T.

Hum Pathol. 2002 Apr;33(4):421-8.

PMID:
12055677
2.

Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.

Lin WM, Forgacs E, Warshal DP, Yeh IT, Martin JS, Ashfaq R, Muller CY.

Clin Cancer Res. 1998 Nov;4(11):2577-83.

4.
5.

PTEN as a molecular marker to distinguish metastatic from primary synchronous endometrioid carcinomas of the ovary and uterus.

Ricci R, Komminoth P, Bannwart F, Torhorst J, Wight E, Heitz PU, Caduff RF.

Diagn Mol Pathol. 2003 Jun;12(2):71-8.

PMID:
12766611
7.

Presence of allelic loss and PTEN mutations in malignant gliomas from Malay patients.

Zainuddin N, Jaafar H, Isa MN, Abdullah JM.

Med J Malaysia. 2004 Oct;59(4):468-79.

8.

beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.

Moreno-Bueno G, Gamallo C, Pérez-Gallego L, de Mora JC, Suárez A, Palacios J.

Diagn Mol Pathol. 2001 Jun;10(2):116-22.

PMID:
11385321
9.

Allelic imbalances in endometrial stromal neoplasms: frequent genetic alterations in the nontumorous normal-appearing endometrial and myometrial tissues.

Moinfar F, Kremser ML, Man YG, Zatloukal K, Tavassoli FA, Denk H.

Gynecol Oncol. 2004 Dec;95(3):662-71.

PMID:
15581979
10.

Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions.

Latini JM, Rieger-Christ KM, Wang DS, Silverman ML, Libertino JA, Summerhayes IC.

J Urol. 2001 Nov;166(5):1931-6.

PMID:
11586263
11.

Loss of heterozygosity and genomic instability in synchronous endometrioid tumors of the ovary and endometrium.

Shenson DL, Gallion HH, Powell DE, Pieretti M.

Cancer. 1995 Aug 15;76(4):650-7.

12.

Molecular analysis of synchronous uterine and ovarian endometrioid tumors.

Emmert-Buck MR, Chuaqui R, Zhuang Z, Nogales F, Liotta LA, Merino MJ.

Int J Gynecol Pathol. 1997 Apr;16(2):143-8.

PMID:
9100068
13.

Allelic imbalance and mutations of the PTEN gene in ovarian cancer.

Saito M, Okamoto A, Kohno T, Takakura S, Shinozaki H, Isonishi S, Yasuhara T, Yoshimura T, Ohtake Y, Ochiai K, Yokota J, Tanaka T.

Int J Cancer. 2000 Jan 15;85(2):160-5.

14.

Genetic classification of combined hepatocellular-cholangiocarcinoma.

Fujii H, Zhu XG, Matsumoto T, Inagaki M, Tokusashi Y, Miyokawa N, Fukusato T, Uekusa T, Takagaki T, Kadowaki N, Shirai T.

Hum Pathol. 2000 Sep;31(9):1011-7.

PMID:
11014564
15.

Common genetic changes between endometriosis and ovarian cancer.

Obata K, Hoshiai H.

Gynecol Obstet Invest. 2000;50 Suppl 1:39-43. Review.

PMID:
11093060
16.

Loss of heterozygosity in clonal evolution with genetic progression and divergence in spindle cell carcinoma of the gallbladder.

Arakawa A, Fujii H, Matsumoto T, Hirai S, Suda K.

Hum Pathol. 2004 Apr;35(4):418-23.

PMID:
15116321
17.

Synchronous endometrial and ovarian carcinomas: analysis of genetic relationship of the tumors.

Nishimura N, Hachisuga T, Nabeshima K, Kawarabayashi T.

Int J Oncol. 2005 Dec;27(6):1519-26.

PMID:
16273207
18.

Synchronous ovarian endometrioid adenocarcinoma with a functioning stroma and endometrial endometrioid adenocarcinoma by different loss of heterozygosity findings.

Takai N, Kai K, Tsuno A, Nasu K, Kashima K, Narahara H.

Arch Gynecol Obstet. 2011 Oct;284(4):951-5. doi: 10.1007/s00404-010-1725-5.

PMID:
21046134
19.

Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.

Obata K, Morland SJ, Watson RH, Hitchcock A, Chenevix-Trench G, Thomas EJ, Campbell IG.

Cancer Res. 1998 May 15;58(10):2095-7.

20.

Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.

Suzuki H, Freije D, Nusskern DR, Okami K, Cairns P, Sidransky D, Isaacs WB, Bova GS.

Cancer Res. 1998 Jan 15;58(2):204-9.

Supplemental Content

Support Center